Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2011
07/21/2011WO2011086136A1 Bacterial host strain comprising a mutant spr gene and having reduced tsp activity
07/21/2011WO2011086118A1 In vivo determination of the lokalization of dna double-stand breaks and application thereof
07/21/2011WO2011085747A1 Novel mannanase variants
07/21/2011WO2011085720A1 Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereof
07/21/2011WO2011085704A1 Chimeric human beta defensins
07/21/2011WO2011085574A1 Complete human anti-tnf-alpha monoclonal antibodies, and manufacturing methods and uses thereof
07/21/2011WO2011085528A1 Method for preparing transgenic animals simultaneously expressing multiple genes
07/21/2011WO2011066372A9 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity
07/21/2011WO2011066008A3 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
07/21/2011WO2011051264A3 Method of treatment
07/21/2011WO2011049329A9 Method for producing transformed earthworms using earthworm gonad-regeneration capability, transformed earthworms thereof, and method for producing recombinant proteins from transformed earthworm body fluids
07/21/2011WO2011049291A3 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfβ, and uses thereof
07/21/2011WO2011039390A3 Mutants of dna polymerase mu
07/21/2011WO2011034906A3 Recurrent gene fusions in prostate cancer
07/21/2011WO2011032166A3 Reprogramming blood cells to pluripotent and multipotent stem cells
07/21/2011WO2011032054A3 Analysis of y-chromosome str markers
07/21/2011WO2011032025A3 Adipose-derived induced pluripotent stem cells
07/21/2011WO2011031477A3 Nucleolin-binding peptides, nucleolin-binding lytic peptides, fusion constructs and methods of making and using same
07/21/2011WO2011031006A3 Cabbage-moth-resistant cabbage transformed by the cryiac gene, and method for producing same
07/21/2011WO2011029013A3 Production of secreted bioproducts from photosynthetic microbes
07/21/2011WO2011022589A3 Detection of enterovirus
07/21/2011WO2011022548A3 Ketoreductase polypeptides for the preparation of phenylephrine
07/21/2011WO2011016632A3 Gene coding for an auxin receptor protein derived from the rice plant, and applications therefor
07/21/2011WO2011012761A3 Procedure for isolating genes involved in the biosynthesis of streptolydigin, molecules of dna, genetic manipulation of the route and uses thereof
07/21/2011WO2011009987A3 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
07/21/2011WO2011008947A3 Treatment and diagnosis of immune disorders
07/21/2011WO2011008517A3 Immunoglobulin fc polypeptides
07/21/2011WO2011006133A3 Bioengineered silk protein-based nucleic acid delivery systems
07/21/2011WO2011006126A3 Engineered microorganisms with enhanced fermentation activity
07/21/2011WO2011003034A3 Biological methods for preparing adipic acid
07/21/2011WO2010151674A3 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
07/21/2011WO2010151671A3 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
07/21/2011WO2010148039A3 Methods and compositions for long fragment read sequencing
07/21/2011WO2010135836A8 Novel beta-glucosidase enzymes
07/21/2011WO2010135749A9 Herpes simplex virus type2: compositions and methods for eliciting an immune response
07/21/2011WO2010135705A3 Biological bar code
07/21/2011WO2010129746A3 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
07/21/2011WO2010111344A3 Methods and microorganisms for production of c4-dicarboxylic acids
07/21/2011WO2010066150A9 Gene network-based method for confirming drug action
07/21/2011WO2008094902A3 Compositions and methods for the detection of a nucleic acid using a cleavage reaction
07/21/2011US20110179530 Pharmaceutical Proteins, Human Therapeutics, Human Serum Albumin Insulin, Native Cholera Toxin B Subunit on Transgenic Plastids
07/21/2011US20110179528 Novel genes involved in biosynthesis
07/21/2011US20110179527 Plants Having Increased Yield and Method for Making the Same
07/21/2011US20110179526 Plants having enhanced yield-related traits and a method for making the same
07/21/2011US20110179524 method for production of moth orchid having modified flower color
07/21/2011US20110179523 Method for Producing a Transgenic Plant Cell, a Plant or a Part Thereof with Increased Resistance Biotic Stress
07/21/2011US20110179522 Defensin polynucleotides and methods of use
07/21/2011US20110179518 Transgenic plants with reduced expression of amadh2 and elevated levels of 2-acetyl-1-pyrroline
07/21/2011US20110179517 Gene expression control in plants
07/21/2011US20110179516 Plants producing 2n pollen
07/21/2011US20110179515 Tomato hybrid ps01059664
07/21/2011US20110179512 Tomato hybrid ps02420487 and parent lines thereof
07/21/2011US20110179511 Isolated rice lp2 promoters and uses thereof
07/21/2011US20110179510 Method for culturing avian gonocytes
07/21/2011US20110179507 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
07/21/2011US20110179506 New i-crei derived single-chain meganuclease and uses thereof
07/21/2011US20110179505 Rodent cancer model for human fgfr4 arg388 polymorphism
07/21/2011US20110179503 Protein production in a host
07/21/2011US20110179502 Modulation of gm98 (mrf) in remyelination
07/21/2011US20110179501 Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B
07/21/2011US20110178289 Construction of new variants of dextransucrase DSR-S by genetic engineering
07/21/2011US20110178277 Stabilized single domain antibodies
07/21/2011US20110178272 Isolated bitter taste receptor polypeptides
07/21/2011US20110178182 Enriched nanostructure composition
07/21/2011US20110178164 Application on monoolein as a new helper lipid in transfection
07/21/2011US20110178155 Silencing of csn5 gene expression using interfering rna
07/21/2011US20110178036 Novel spinosyn-producing polyketide synthases
07/21/2011US20110178030 Methods of treating inflammatory intestinal disease and managing symptoms thereof
07/21/2011US20110178026 Ricin-like toxins for treatment of cancer
07/21/2011US20110178020 Methods and compositions for inhibition of neutrophil exocytosis
07/21/2011US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
07/21/2011US20110177997 Cross-Beta Silk Genes
07/21/2011US20110177990 Amylase Variants
07/21/2011US20110177965 Compositions and methods for prognosis of gastric cancer
07/21/2011US20110177615 Protein expression
07/21/2011US20110177600 Protein production using eukaryotic cell lines
07/21/2011US20110177599 Delivery of nucleic acids across membranes
07/21/2011US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
07/21/2011US20110177589 Novel human polyomavirus
07/21/2011US20110177569 Mutant of propionyl-coa transferase from clostridium propionicum and preparing method for pla or pla copolymer using the same
07/21/2011US20110177568 Method of L-Lysine Production
07/21/2011US20110177561 Novel CBH1 Homologs And Varian CBH1 Cellulase
07/21/2011US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides
07/21/2011US20110177554 Secreted frizzled related protein, sfrp, fragments and methods of use thereof
07/21/2011US20110177553 Preparation of an esterase
07/21/2011US20110177540 Mutant luciferase
07/21/2011US20110177520 Dna sequencing method
07/21/2011US20110177510 Method and probe set for detecting cancer
07/21/2011US20110177497 Thermus Thermophilus Nucleic Acid Polymerases
07/21/2011US20110177495 Continuous directed evolution of proteins and nucleic acids
07/21/2011US20110177228 Plant nucelotide sequences and corresponding polypeptides
07/21/2011US20110177160 Amino acid lipids and uses thereof
07/21/2011US20110177131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSION
07/21/2011US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
07/21/2011US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
07/21/2011US20110177095 Anti-her2 antibodies and their uses
07/21/2011US20110177085 Bitter Taste Receptors
07/21/2011US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/21/2011US20110177079 Cancer-testis antigens
07/21/2011US20110177076 Humanized anti-amyloid beta antibodies